Efficacy of combination therapy using twice-a-day IFN-β followed by IFN-α for chronic hepatitis C.

被引：0
|
作者：
Chikazawa, H [1 ]
Fujiyama, S [1 ]
Tanaka, M [1 ]
Honda, Y [1 ]
Sugi, K [1 ]
Tomita, K [1 ]
机构：
[1] Kumamoto Univ, Sch Med, Dept Internal Med 3, Kumamoto 860, Japan
来源：
HEPATOLOGY | 1998年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2182
引用
收藏
页码：708A / 708A
页数：1
相关论文
共 50 条
  • [31] Minimal change disease in a patient receiving IFN-α therapy for chronic hepatitis C virus infection
    Dizer, U
    Beker, CM
    Yavuz, I
    Ortatatli, M
    Ozguven, V
    Pahsa, A
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2003, 23 (01): : 51 - 54
  • [32] Suicidal ideation with IFN-α and ribavirin in a patient with hepatitis C
    Ademmer, K
    Beutel, M
    Bretzel, R
    Clemens, J
    Reimer, C
    PSYCHOSOMATICS, 2001, 42 (04) : 365 - 367
  • [33] The use of IFN-α in subjects with liver transplant for hepatitis C
    Gattoni, A.
    Plaitano, E.
    Vangieri, B.
    Parlato, A.
    Giordano, A.
    PANMINERVA MEDICA, 2009, 51 (03) : 187 - 188
  • [34] A RCT of high-dose IFN induction followed by combination therapy with ribavirin in naive patients with chronic hepatitis C.
    Vaccaro, A
    Di Marco, V
    Ferraro, D
    Parisi, P
    Cappello, M
    Cino, N
    Di Stefano, R
    Almasio, PL
    Craxi, A
    HEPATOLOGY, 2000, 32 (04) : 363A - 363A
  • [35] Randomized, controlled trial with interferon-α (IFN-α) combined with ribavirin with and without amantadinsulfat in primary IFN-α non-responders with chronic hepatitis C
    Teuber, G
    Berg, T
    Lafrenz, M
    Weidenbach, H
    Schoelmerich, J
    Wietzke-Braun, P
    Pausch, J
    Arnold, R
    Lock, G
    Udo, H
    Zeuzem, S
    GASTROENTEROLOGY, 2001, 120 (05) : A381 - A381
  • [36] Alterations of leptin levels during IFN-α treatment in patients with chronic viral hepatitis B and C:: Evidence of an IFN-α-mediated suppression of leptin production
    Liaskos, C
    Zografos, TA
    Togousidis, E
    Zachou, K
    Gatselis, N
    Rigopoulou, E
    Germenis, A
    Dalekos, GN
    HEPATOLOGY, 2005, 42 (04) : 673A - 673A
  • [37] Oxidative stress and IFN plus ribavirin combination therapy in patients with chronic hepatitis C.
    Morisco, F
    Verde, V
    Fogliano, V
    Ritieni, A
    Iasevoli, P
    Tuccillo, C
    De Luise, G
    Caporaso, N
    GASTROENTEROLOGY, 2000, 118 (04) : A1471 - A1471
  • [38] Rapid and simple detection of IFN-neutralizing antibodies in chronic hepatitis C non-responsive to IFN-α
    Jorns, C
    Holzinger, D
    Thimme, R
    Spangenberg, HC
    Weidmann, M
    Rasenack, J
    Blum, HE
    Haller, O
    Kochs, G
    JOURNAL OF MEDICAL VIROLOGY, 2006, 78 (01) : 74 - 82
  • [39] Effect of consensus IFN and ribavirin in combination with IFN on host factors in patients with chronic hepatitis C.
    Shinohara, M
    Ishii, K
    Takamura, N
    Wakui, N
    Shin, H
    Ikehara, T
    Kawafune, T
    Sugimoto, M
    Yamamuro, W
    Sumino, Y
    HEPATOLOGY, 2002, 36 (04) : 600A - 600A
  • [40] Long term efficacy of induction IFN therapy for 4 weeks followed by a standard tiw schedule in chronic hepatitis C.
    Hadziyannis, AS
    Papaioannou, C
    Spanou, F
    Hadziyannis, SJ
    HEPATOLOGY, 1998, 28 (04) : 378A - 378A
12345